Rapid clinical response to nemolizumab in a patient with lichen amyloidosis
Kaito Iwama, Daiki Rokunohe, Kazuhito Kogawa, Eijiro Akasaka · 2026
Read Rapid clinical response to nemolizumab in a patient with lichen amyloidosis by Kaito Iwama, Daiki Rokunohe, Kazuhito Kogawa, Eijiro Akasaka (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-13320313.txt.
Description
Kaito Iwama and three co-authors reported a 2026 case of fast relief for a stubborn itchy skin disease. A 60-year-old man had suffered for over ten years with what was treated as eczema. His itch scored 9 out of 10 and broke his sleep. Creams and antihistamines had failed. Raised, rough bumps covered his elbows, knees, and upper back.
A biopsy showed amyloid deposits in the upper skin layer, confirming lichen amyloidosis. Doctors gave nemolizumab, an antibody drug that blocks a key itch signal receptor. His itch score and skin scores fell quickly, with photos showing clear gains by two and twelve weeks. The case suggests a new option for a disease with few good treatments.
Catalog record
| CREATOR | Kaito Iwama, Daiki Rokunohe, Kazuhito Kogawa, Eijiro Akasaka |
|---|---|
| YEAR | 2026 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 8 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |